Memory Deterioration in Alzheimer Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age55+
SponsorNorwegian University of Science and Technology
About this trial
Semantic AD
Eligibility criteria
Qualifiers
Confirmed diagnosis based on current ICD criteria for AD or MCI .
>55years.
Norwegian native speaker
Lives at home and not in a health institution
Disqualifiers
Patients with severe cognitive impairment that prevents assessment with the selected modalities (planned cut-off: CDR > 2).
Presence of brain tumors.
History of traumatic brain injury.
History of cranial surgery.
Trial design
Treatments tested in this trial
- 7T MRI
- EEG
- Blood samples
- Stool samples
- Neuropsychologic test (MoCA)
Treatment groups
30 Participants
are divided into 2 treatment groupsLocations
1Norwegian University of Sciene and Technology / Norges teknisk-naturvitenskapelige universitet (NTNU)7030, TrondheimTrønderlag, Norway
Sponsors and collaborators
Norwegian University of Science and Technology
Lead sponsor
Source ClinicalTrials.gov